Clinical Trial

Safety and Efficacy of ZVS101e in Patients With Bietti 's Crystalline Dystrophy

Active, Not Recruiting Phase 1/2
View on ClinicalTrials.gov →
Summary
The purpose of this study was to evaluate the safety and efficacy of ZVS101e administered by subretinal injection in subjects with Bietti's crystalline dystrophy (BCD) and to select the optimal effective dose.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-04-16; most recent amendment 2026-06-15.
Status change: Recruiting → Active, Not Recruiting 2024-08-26
Trial Details
NCT Number NCT05832684
Lead Sponsor Chigenovo Co., Ltd
Conditions Bietti's Crystalline Dystrophy
Enrollment 24 participants
Start Date 2023-02-20
Primary Completion 2024-07-23 (estimated)
Study Completion 2028-12 (estimated)
Updated on ClinicalTrials.gov 2026-06-17